Similar Items: Advancing tuberculosis treatment through pharmacometric modeling of drug exposure and biomarkers
- Addressing challenges in the treatment of tuberculosis and tuberculosis meningitis: a pharmacometric approach
- Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations
- Combining different types of highly parallelised technology datasets for bioinformatic analysis in the context of biomarker discovery for tuberculosis disease and treatment response
- Diagnostic and therapeutic biomarker responses in HIV and tuberculosis co-infected patients
- Evaluation of host biomarkers for early diagnosis of tuberculosis disease in children
- Analysis of ex vivo host biomarkers in sputum samples for diagnosis of pulmonary tuberculosis
Author: Denti, Paolo
- Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
- Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- A scoping review on the use of telerehabilitation in physiotherapy in low and middle income countries
- Advancing tuberculosis treatment through pharmacometric modeling of drug exposure and biomarkers